Success Metrics

Clinical Success Rate
92.0%

Based on 46 completed trials

Completion Rate
92%(46/50)
Active Trials
18(23%)
Results Posted
11%(5 trials)
Terminated
4(5%)

Phase Distribution

Ph not_applicable
64
82%
Ph phase_4
2
3%
Ph phase_1
3
4%

Phase Distribution

3

Early Stage

0

Mid Stage

2

Late Stage

Phase Distribution69 total trials
Phase 1Safety & dosage
3(4.3%)
Phase 4Post-market surveillance
2(2.9%)
N/ANon-phased studies
64(92.8%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

88.5%

46 of 52 finished

Non-Completion Rate

11.5%

6 ended early

Currently Active

18

trials recruiting

Total Trials

78

all time

Status Distribution
Active(20)
Completed(46)
Terminated(6)
Other(6)

Detailed Status

Completed46
Recruiting16
unknown6
Terminated4
Active, not recruiting2
Withdrawn2

Development Timeline

Analytics

Development Status

Total Trials
78
Active
18
Success Rate
92.0%
Most Advanced
Phase 4

Trials by Phase

Phase 13 (4.3%)
Phase 42 (2.9%)
N/A64 (92.8%)

Trials by Status

active_not_recruiting23%
terminated45%
withdrawn23%
recruiting1621%
enrolling_by_invitation11%
completed4659%
unknown68%
not_yet_recruiting11%

Recent Activity

Clinical Trials (78)

Showing 20 of 78 trialsScroll for more
NCT06424132Not Applicable

Thermogenic Silencer Regulatory Factors in Humans

Active Not Recruiting
NCT07527208Not Applicable

The Meta-SHIFT Study: How Metabolic Shift Shapes Human Immunometabolism - a Fasting Trial

Completed
NCT07009288Not Applicable

A Study of Time-Restricted Eating in Childhood Cancer Survivors

Recruiting
NCT07738536Not Applicable

Ketosis, Immune Function and Metabolic Adaptation in Response to Short-term Fasting in Critical Illness

Not Yet Recruiting
NCT05545306Not Applicable

The Effects of Increasing Caloric Intake on Diet-Induced Thermogenesis and 24h Energy Expenditure

Recruiting
NCT06536881Not Applicable

Gut Microbiome, Adverse Effects, and Markers Through MEtabolic Reprogramming

Recruiting
NCT06645093Not Applicable

Feasibility of Intermittent Fasting During Chemotherapy

Recruiting
NCT07216989

Fastomics: Metabolic and Therapeutic Effects of Prolonged Fasting

Completed
NCT06826924Not Applicable

7-Days Water-Only Fasting or Ketone Supplementation Trial in Prostate Cancer

Recruiting
NCT06751043Not Applicable

Preoperative Fasting vs. Not Fasting in Critically Ill Patients

Recruiting
NCT06789172Phase 1

A Phase 1, First-in-human Study of OKN4395 and Pembrolizumab in Patients With Solid Tumors

Recruiting
NCT06748027

Guidelines on Long-term Medical Fasting

Enrolling By Invitation
NCT06307275Not Applicable

Intermittent Fasting on Body Fat and Quality of Life

Recruiting
NCT06425731Not Applicable

Dance and Energy Expenditure Among Adults With Parkinson's

Recruiting
NCT07508293

Continuous Enteral Feeding Until Tracheostomy and Aspiration Risk

Completed
NCT05819801Not Applicable

Effect of Fasting on Patient Outcomes After Wide-Awake, Local Anesthesia-only, No Tourniquet (WALANT) Procedures

Recruiting
NCT06172088Not Applicable

Exploratory Study Therapeutic Fasting Reduce Physical Limitations, Quality of Life During Aromatase Inhibitor Therapy

Completed
NCT06115148Not Applicable

Breath Analysis & Malnutrition

Recruiting
NCT06996639Not Applicable

Breaking Fasts Ahead of Cardiac Caths

Recruiting
NCT07250191Not Applicable

The Effects of 24-hour Fasting or Carbohydrate Restriction on Postprandial Metabolic Responses

Completed

Drug Details

Intervention Type
OTHER
Total Trials
78